Literature DB >> 19091900

The significance of cardiac sympathetic nervous system abnormality in the long-term prognosis of patients with a history of ventricular tachyarrhythmia.

Yasushi Akutsu1, Kyouichi Kaneko, Yusuke Kodama, Hui-Ling Li, Mitsuharu Kawamura, Taku Asano, Kaoru Tanno, Akira Shinozuka, Takehiko Gokan, Youichi Kobayashi.   

Abstract

UNLABELLED: Severe left ventricular dysfunction or cardiac sympathetic nervous system (SNS) abnormality predicts cardiac death in various heart diseases, including arrhythmogenic disorders. However, it is not clear whether SNS abnormality predicts sudden cardiac death during long-term follow-up in patients with a history of ventricular tachyarrhythmia. We hypothesized that SNS abnormality would be associated with recurrent ventricular arrhythmic events.
METHODS: 123I-metaiodobenzylguanidine (MIBG) scintigraphy was performed on 86 patients (mean age+/-SD, 46+/-19 y, 65.1% men) with a history of ventricular tachycardia or fibrillation. 123I-MIBG (111 MBq) was intravenously administered under resting conditions, and planar images were obtained 15 min and 4 h later (anterior view for 6 min; 512x512 matrices; zoom ratio, 1.0). SNS activity was assessed using the heart-to-mediastinum ratio on delayed imaging.
RESULTS: During about 11 y of follow-up (mean+/-SD, 5.2+/-3.7 y), 3 patients (3.5%) had sudden cardiac death and 21 patients (24.4%) had sustained ventricular tachyarrhythmic events. SNS abnormality, defined as a heart-to-mediastinum ratio of less than 2.8, and left ventricular dysfunction, defined as a left ventricular ejection fraction of less than 50%, were associated with sudden cardiac death or recurrent ventricular tachyarrhythmic events (18/40 patients [45%] with SNS abnormality, vs. 6/46 patients [13%] without, P=0.004; 9/15 patients [60%] with left ventricular dysfunction, vs. 15/71 patients [21.1%] without, P=0.008). After adjustment for potential confounding variables such as age, sex, coronary risk factors, medication use, history of structural heart disease, and left ventricular function, SNS abnormality was a powerful predictor of recurrent arrhythmic events, with a hazard ratio of 3.6 [95% confidence interval, 1.4-9.2, P=0.007]). Further, SNS abnormality had incremental and additive prognostic power in combination with left ventricular dysfunction, with an adjusted hazard ratio of 4.4 [95% confidence interval, 1.9-9.9, P<0.0001]).
CONCLUSION: SNS abnormality predicted recurrent ventricular tachyarrhythmic events during long-term follow-up. 123I-MIBG scintigraphic evaluations for SNS abnormality may be an option for screening patients at high risk for sudden cardiac death.

Entities:  

Mesh:

Year:  2008        PMID: 19091900     DOI: 10.2967/jnumed.108.055194

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

Review 1.  Molecular imaging in cardiovascular disease: targets and opportunities.

Authors:  Stanley Y Shaw
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

Review 2.  The Role of Atrial Structural Remodeling in Atrial Fibrillation Ablation:An Imaging Point of View for Predicting Recurrence.

Authors:  Yasushi Akutsu; Kaoru Tanno; Youichi Kobayashi
Journal:  J Atr Fibrillation       Date:  2012-08-20

3.  Oscillatory vagal maneuvers produce ventricular entrainment in patients with atrial fibrillation.

Authors:  Christina F Pacchia; Geoff P Kline; Mohamed H Hamdan; Kari G Clark; Michael G Clark; Michael L Smith
Journal:  Clin Auton Res       Date:  2011-05-07       Impact factor: 4.435

4.  Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: 11C-hydroxyephedrine PET study.

Authors:  Tadao Aikawa; Masanao Naya; Masahiko Obara; Noriko Oyama-Manabe; Osamu Manabe; Keiichi Magota; Yoichi M Ito; Chietsugu Katoh; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-26       Impact factor: 9.236

5.  Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.

Authors:  Shu Kasama; Takuji Toyama; Yoshiaki Kaneko; Toshiya Iwasaki; Hiroyuki Sumino; Hisao Kumakura; Kazutomo Minami; Shuichi Ichikawa; Naoya Matsumoto; Yuichi Sato; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-14       Impact factor: 9.236

6.  Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Hui-Ling Li; Jumpei Suyama; Akira Shinozuka; Takehiko Gokan; Mitsuharu Kawamura; Taku Asano; Yuji Hamazaki; Kaoru Tanno; Youichi Kobayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

7.  PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.

Authors:  Paul E Kinahan; Robert K Doot; Michelle Wanner-Roybal; Luc M Bidaut; Samuel G Armato; Charles R Meyer; Geoffrey McLennan
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

Review 8.  Age related cardiovascular dysfunction and effects of physical activity.

Authors:  Fabio Galetta; Angelo Carpi; Nader Abraham; Emanuele Guidotti; Matteo A Russo; Marcello Camici; Alessandro Antonelli; Ferdinando Franzoni; Gino Santoro
Journal:  Front Biosci (Elite Ed)       Date:  2012-06-01

Review 9.  The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathy.

Authors:  Thomas Klein; Vasken Dilsizian; Qi Cao; Wengen Chen; Timm-Michael Dickfeld
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

10.  Pulmonary vein isolation in patients with paroxysmal atrial fibrillation is associated with regional cardiac sympathetic denervation.

Authors:  Christian Wenning; Philipp S Lange; Christoph Schülke; Alexis Vrachimis; Gerold Mönnig; Otmar Schober; Lars Eckardt; Michael Schäfers
Journal:  EJNMMI Res       Date:  2013-12-21       Impact factor: 3.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.